arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 9/2011 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Early benefit assessment: is the Pharmaceutical Market Restructuring Act in Germany (AMNOG) a break on innovation?

    NEW ON THE MARKET

    Thrombin inhibitor dabigatran (PRADAXA) for nonvalvular atrial fibrillation

    Protease inhibitor boceprevir (VICTRELIS) for chronic hepatitis C

    a-t READER'S QUESTIONS AND COMMENTS

    Are pre-filled syringes without integrated needle protection obsolete?

    CURRENT ADR NETWORK REPORT

    Liver damage with analgesic flupirtine (KATADOLON, generics)

    SIDE EFFECTS

    E.g. clozapine (LEPONEX, generics): bedwetting with atypical antipsychotics in adults
    free

    QT interval prolongation with SSRI citalopram (CIPRAMIL, generics)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles